CN109200232A - 一种治疗牛皮癣的药物 - Google Patents
一种治疗牛皮癣的药物 Download PDFInfo
- Publication number
- CN109200232A CN109200232A CN201811238536.1A CN201811238536A CN109200232A CN 109200232 A CN109200232 A CN 109200232A CN 201811238536 A CN201811238536 A CN 201811238536A CN 109200232 A CN109200232 A CN 109200232A
- Authority
- CN
- China
- Prior art keywords
- paste
- parts
- raw material
- western medicine
- medicine raw
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000002682 anti-psoriatic effect Effects 0.000 title claims abstract description 19
- 229940030999 antipsoriatics Drugs 0.000 title claims abstract description 19
- 239000003814 drug Substances 0.000 claims abstract description 85
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims abstract description 69
- 239000002994 raw material Substances 0.000 claims abstract description 54
- 238000000034 method Methods 0.000 claims abstract description 36
- 230000008569 process Effects 0.000 claims abstract description 35
- 238000002347 injection Methods 0.000 claims abstract description 11
- 239000007924 injection Substances 0.000 claims abstract description 11
- 239000002775 capsule Substances 0.000 claims abstract description 10
- 229960002117 triamcinolone acetonide Drugs 0.000 claims abstract description 10
- YNDXUCZADRHECN-JNQJZLCISA-N triamcinolone acetonide Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@@H]2O YNDXUCZADRHECN-JNQJZLCISA-N 0.000 claims abstract description 10
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 claims abstract description 9
- 241001671204 Stemona Species 0.000 claims abstract description 9
- 229940116229 borneol Drugs 0.000 claims abstract description 9
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 claims abstract description 9
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 claims abstract description 9
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 8
- 241000605422 Asparagus asparagoides Species 0.000 claims abstract description 8
- 235000008702 Ilex rotunda Nutrition 0.000 claims abstract description 8
- 241000519740 Ilex rotunda Species 0.000 claims abstract description 8
- 241000717679 Mosla Species 0.000 claims abstract description 8
- 240000003152 Rhus chinensis Species 0.000 claims abstract description 8
- 235000014220 Rhus chinensis Nutrition 0.000 claims abstract description 8
- 241000316658 Sauromatum giganteum Species 0.000 claims abstract description 8
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 claims description 18
- 229960003260 chlorhexidine Drugs 0.000 claims description 18
- 239000000463 material Substances 0.000 claims description 18
- 239000000843 powder Substances 0.000 claims description 16
- 229940099259 vaseline Drugs 0.000 claims description 14
- 239000002674 ointment Substances 0.000 claims description 11
- 238000004519 manufacturing process Methods 0.000 claims description 8
- 238000012856 packing Methods 0.000 claims description 8
- LPNITZFOZWXKMB-UHFFFAOYSA-N acetic acid;molecular chlorine Chemical compound ClCl.CC(O)=O LPNITZFOZWXKMB-UHFFFAOYSA-N 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 21
- 238000011084 recovery Methods 0.000 abstract description 3
- 201000004681 Psoriasis Diseases 0.000 description 22
- 229940079593 drug Drugs 0.000 description 15
- 230000001151 other effect Effects 0.000 description 11
- 230000001225 therapeutic effect Effects 0.000 description 6
- 231100000614 poison Toxicity 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 230000000844 anti-bacterial effect Effects 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 238000001784 detoxification Methods 0.000 description 4
- 230000004060 metabolic process Effects 0.000 description 4
- 239000003440 toxic substance Substances 0.000 description 4
- 241000222122 Candida albicans Species 0.000 description 3
- 241000130764 Tinea Species 0.000 description 3
- 208000002474 Tinea Diseases 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 229940095731 candida albicans Drugs 0.000 description 3
- 230000002757 inflammatory effect Effects 0.000 description 3
- 239000006210 lotion Substances 0.000 description 3
- 238000010926 purge Methods 0.000 description 3
- 239000003053 toxin Substances 0.000 description 3
- 231100000765 toxin Toxicity 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- ZSBXGIUJOOQZMP-UHFFFAOYSA-N Isomatrine Natural products C1CCC2CN3C(=O)CCCC3C3C2N1CCC3 ZSBXGIUJOOQZMP-UHFFFAOYSA-N 0.000 description 2
- ZSBXGIUJOOQZMP-JLNYLFASSA-N Matrine Chemical compound C1CC[C@H]2CN3C(=O)CCC[C@@H]3[C@@H]3[C@H]2N1CCC3 ZSBXGIUJOOQZMP-JLNYLFASSA-N 0.000 description 2
- 241000191940 Staphylococcus Species 0.000 description 2
- 244000052616 bacterial pathogen Species 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 238000011461 current therapy Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 238000010255 intramuscular injection Methods 0.000 description 2
- 239000007927 intramuscular injection Substances 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 229930014456 matrine Natural products 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 208000017520 skin disease Diseases 0.000 description 2
- 238000010025 steaming Methods 0.000 description 2
- 239000002344 surface layer Substances 0.000 description 2
- ANJTVLIZGCUXLD-BDAKNGLRSA-N (-)-Cytisine Natural products C1NC[C@@H]2CN3C(=O)C=CC=C3[C@H]1C2 ANJTVLIZGCUXLD-BDAKNGLRSA-N 0.000 description 1
- FFRBMBIXVSCUFS-UHFFFAOYSA-N 2,4-dinitro-1-naphthol Chemical compound C1=CC=C2C(O)=C([N+]([O-])=O)C=C([N+]([O-])=O)C2=C1 FFRBMBIXVSCUFS-UHFFFAOYSA-N 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 229930008564 C01BA04 - Sparteine Natural products 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 206010008631 Cholera Diseases 0.000 description 1
- 244000301850 Cupressus sempervirens Species 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010016717 Fistula Diseases 0.000 description 1
- 241000726221 Gemma Species 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 241000893976 Nannizzia gypsea Species 0.000 description 1
- 240000002853 Nelumbo nucifera Species 0.000 description 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 1
- 206010033733 Papule Diseases 0.000 description 1
- 241000606860 Pasteurella Species 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 241000669298 Pseudaulacaspis pentagona Species 0.000 description 1
- 241000218682 Pseudolarix amabilis Species 0.000 description 1
- 206010037888 Rash pustular Diseases 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 241000362909 Smilax <beetle> Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 241000223238 Trichophyton Species 0.000 description 1
- 240000004922 Vigna radiata Species 0.000 description 1
- 235000010721 Vigna radiata var radiata Nutrition 0.000 description 1
- 235000011469 Vigna radiata var sublobata Nutrition 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- SLRCCWJSBJZJBV-UHFFFAOYSA-N alpha-isosparteine Natural products C1N2CCCCC2C2CN3CCCCC3C1C2 SLRCCWJSBJZJBV-UHFFFAOYSA-N 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 208000027503 bloody stool Diseases 0.000 description 1
- 125000002604 borneol group Chemical group 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 229930017327 cytisine Natural products 0.000 description 1
- ANJTVLIZGCUXLD-DTWKUNHWSA-N cytisine Chemical compound C1NC[C@H]2CN3C(=O)C=CC=C3[C@@H]1C2 ANJTVLIZGCUXLD-DTWKUNHWSA-N 0.000 description 1
- 229940027564 cytisine Drugs 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 208000013219 diaphoresis Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- ANJTVLIZGCUXLD-UHFFFAOYSA-N ent-cytisine Natural products C1NCC2CN3C(=O)C=CC=C3C1C2 ANJTVLIZGCUXLD-UHFFFAOYSA-N 0.000 description 1
- 230000003890 fistula Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000017525 heat dissipation Effects 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000001114 myogenic effect Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- OIGNJSKKLXVSLS-VWUMJDOOSA-N prednisolone Chemical compound O=C1C=C[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 OIGNJSKKLXVSLS-VWUMJDOOSA-N 0.000 description 1
- 208000029561 pustule Diseases 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 206010040882 skin lesion Diseases 0.000 description 1
- 231100000444 skin lesion Toxicity 0.000 description 1
- SLRCCWJSBJZJBV-AJNGGQMLSA-N sparteine Chemical compound C1N2CCCC[C@H]2[C@@H]2CN3CCCC[C@H]3[C@H]1C2 SLRCCWJSBJZJBV-AJNGGQMLSA-N 0.000 description 1
- 229960001945 sparteine Drugs 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/13—Coniferophyta (gymnosperms)
- A61K36/15—Pinaceae (Pine family), e.g. pine or cedar
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/234—Cnidium (snowparsley)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/29—Berberidaceae (Barberry family), e.g. barberry, cohosh or mayapple
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/483—Gleditsia (locust)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/489—Sophora, e.g. necklacepod or mamani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
- A61K36/575—Magnolia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/58—Meliaceae (Chinaberry or Mahogany family), e.g. Azadirachta (neem)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/62—Nymphaeaceae (Water-lily family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/756—Phellodendron, e.g. corktree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/83—Thymelaeaceae (Mezereum family), e.g. leatherwood or false ohelo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
- A61K36/8884—Arisaema, e.g. Jack in the pulpit
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
- A61K36/8888—Pinellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/90—Smilacaceae (Catbrier family), e.g. greenbrier or sarsaparilla
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/904—Stemonaceae (Stemona family), e.g. croomia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Insects & Arthropods (AREA)
- Dermatology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Marine Sciences & Fisheries (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Husbandry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
一种治疗牛皮癣的药物,包括曲安奈德注射液、黄柏胶囊,还具有膏剂A、膏剂B,膏剂A包括中药原材料和西药原材料,膏剂A中药原材料包括土槿皮、苦参、蛇床子、白鲜皮、黄柏、五倍子、鞭蓉叶、皂角刺、独角莲、百部、土茯苓、七星剑、铁冬青,膏剂A西药原材料是醋酸氯已定,膏剂A的中药原材料、西药原材料混合加工制成膏剂A成品;膏剂B包括包括中药原材料和西药原材料,膏剂B中药原材料包括狼毒、蛇床子、厚朴、苦参、黄柏、珍珠、冰片,膏剂B西药原材料是醋酸氯已定,膏剂B的中药原材料、西药原材料混合加工制成膏剂B成品;加工而成的膏剂A、膏剂B即是治疗牛皮癣的药物成品。本发明能起到好的治愈效果,痊愈后不容易复发。
Description
技术领域
本发明涉及中西药应用领域,特别是一种治疗牛皮癣的药物。
背景技术
牛皮癣,是一种常见的具有特征性皮损的慢性、易于复发的炎症性皮肤病。初起为炎性红色丘疹,约粟粒至绿豆大小,以后逐渐扩大或融合成为棕红色斑块,边界清楚,周围有炎性红晕,基底浸润明显,表面覆盖多层干燥的灰白色或银白色鳞屑,故而也称为银屑病。牛皮癣根据临床表现可以分为:寻常型 、脓疱型、 红皮病型 、关节病型 ,四种牛皮癣的发病机制主因是肌体代谢产生的有害产物渗杂在血液细胞间质中,导致肌体内环境污染,从而造成血液纯质的改变,出现血热、血燥、血瘀、蕴积滞阻过多现象,进而导致瘟毒发于肌肤形成牛皮癣,牛皮癣难以根治、因此长年反复发作、病程迁延,会给患者带来肌肤失养、枯燥瘙痒、伤神失眠、摧残身体等不良影响,而且由于牛皮癣暴露在肌肤表层,直接影响了人的整体美观。
现有医疗领域中,治疗牛皮癣的方式主要分为内服药和患处直接擦药治疗,长期内服药会给人包括肠胃等的身体健康带来影响,而且还存在效果不佳、容易复发的缺点。现有治疗牛皮癣的外用药,由于配方组合不合理,也存在治疗效果不好、易复发的缺点。
发明内容
为了克服现有长期内服药物治疗牛皮癣会对人的健康带来影响,还存在治疗效果不好、容易复发等的缺点,以及现有治疗牛皮癣的外用药因配方组合不合理,治疗效果不佳、容易复发的弊端,本发明采用多种对牛皮癣有良好治疗效果的中药配比为伍,并结合醋酸氯已定等西药制成方便擦拭的膏剂,治疗时结合曲安奈德注射液肌肉注射,外加内服黄柏胶囊,各种药物由内而外能有效作用于患处,达到深入患处肌肤、调节患处血液循环、促进新陈代谢、排出毒素,从根源上治疗牛皮癣、且不易复发目地的一种治疗牛皮癣的药物。
本发明解决其技术问题所采用的技术方案是:
一种治疗牛皮癣的药物,包括曲安奈德注射液、黄柏胶囊,其特征在于还具有膏剂A、膏剂B,膏剂A包括中药原材料和西药原材料,膏剂A中药原材料包括土槿皮、苦参、蛇床子、白鲜皮、黄柏、五倍子、鞭蓉叶、皂角刺、独角莲、百部、土茯苓、七星剑、铁冬青,膏剂A西药原材料是醋酸氯已定,膏剂A的中药原材料、西药原材料混合加工制成膏剂A成品;膏剂B包括包括中药原材料和西药原材料,膏剂B中药原材料包括狼毒、蛇床子、厚朴、苦参、黄柏、珍珠、冰片,膏剂B西药原材料是醋酸氯已定,膏剂B的中药原材料、西药原材料混合加工制成膏剂B成品;加工而成的膏剂A、膏剂B即是治疗牛皮癣的药物成品。
所述膏剂A中药原材料中,各原料份量如下:土槿皮2-3份、苦参1-2份、蛇床子2-4份、白鲜皮2-2.5份、黄柏2-4份、五倍子1-2份、鞭蓉叶2-4份、皂角刺0.2-0.8份、独角莲2-4份、百部0.2-0.8份、土茯苓2-4份、七星剑0.2-0.8份、铁冬青0.3-0.8份。
所述膏剂A西药原材料醋酸氯已定份量是0.1-0.5份。
所述进行膏剂A的中药原材料、西药原材料混合加工制成膏剂A成品工序时,先将各中药原料用粉碎机粉碎至200目的粉末,把粉碎后药粉和醋酸氯已定在容器内调和均匀,调和过程中逐渐加入白凡士林,凡士林全部加入并调和均匀后即可得到膏剂A成品,将成品膏剂A装入软膏包装容器内即完成所有膏剂A加工工序,凡士林的用量保证中药原材料、西药原材料混合均匀即可。
所述膏剂B中药原材料中,各原料份量如下:狼毒0.03-0.06份、蛇床子2-4份、厚朴0.4-0.7份、苦参1-2份、黄柏2-4份、珍珠0.3-0.7份、冰片1.5-2.6份.
所述膏剂B西药原材料醋酸氯已定份量是0.1-0.3份。
所述进行膏剂B的中药原材料、西药原材料混合加工制成膏剂B成品工序时,先将各中药原料用粉碎机粉碎至200目的粉末,把粉碎后药粉和醋酸氯已定在容器内调和均匀,调和过程中逐渐加入白凡士林,凡士林全部加入并调和均匀后即可得到膏剂B成品,将成品膏剂B装入软膏包装容器内即完成所有膏剂B加工工序,凡士林的用量保证中药原材料、西药原材料混合均匀即可。
本发明有益效果是:本发明使用时,将牛皮癣表层用医疗工具刮干净,然后将膏剂A、膏剂B各适量涂抹在患处上并涂抹均匀,膏剂B用量为膏剂A的一半。然和结合曲安奈德注射液肌肉注射每天一次,外加内服黄柏胶囊每天六粒(注射及内服药物一般时间为一周)。本发明的曲安奈德注射液以及膏剂A、膏剂B、醋酸氯已定对牛皮癣致病菌金黄色葡萄球菌和白色念珠菌等均有良好的抑制作用,黄柏胶囊具有清热燥湿,泻火除蒸,解毒疗疮的功效,各中药和西药有效成分由内而外直接作用于患处,深入患处的血液循环,能促进患处的新陈代谢,达到好的排毒去毒效果,显效快,从根源上治疗牛皮癣、且不易复发,即治标又治本,能起到好的治愈效果,且由于对发病根源进行了有效治疗,痊愈后不容易复发。本发明组方严谨、使用方便,治愈效果好,因此具有好的应用前景。
附图说明
图1是本发明一种治疗牛皮癣的药物的组成示意图。
具体实施方式
图1中所示,一种治疗牛皮癣的药物,包括曲安奈德注射液、黄柏胶囊,其特征在于还具有膏剂A、膏剂B,膏剂A包括中药原材料和西药原材料,膏剂A中药原材料包括土槿皮、苦参、蛇床子、白鲜皮、黄柏、五倍子、鞭蓉叶、皂角刺、独角莲、百部、土茯苓、七星剑、铁冬青,膏剂A西药原材料是醋酸氯已定,膏剂A的中药原材料、西药原材料混合加工制成膏剂A成品;膏剂B包括包括中药原材料和西药原材料,膏剂B中药原材料包括狼毒、蛇床子、厚朴、苦参、黄柏、珍珠、冰片,膏剂B西药原材料是醋酸氯已定,膏剂B的中药原材料、西药原材料混合加工制成膏剂B成品;加工而成的膏剂A、膏剂B即是治疗牛皮癣的药物成品。
图1中所示,实施例1中,膏剂A中药原材料中,各原料份量如下:土槿皮2份、苦参1.5份、蛇床子3份、白鲜皮2份、黄柏3份、五倍子1.5份、鞭蓉叶3份、皂角刺0.6份、独角莲4份、百部0.6份、土茯苓3.5份、七星剑0.5份、铁冬青0.7份。膏剂A西药原材料醋酸氯已定份量是0.4份。进行膏剂A的中药原材料、西药原材料混合加工制成膏剂A成品工序时,先将各中药原料用粉碎机粉碎至200目的粉末,把粉碎后药粉和醋酸氯已定在容器内调和均匀,调和过程中逐渐加入白凡士林,凡士林全部加入并调和均匀后即可得到膏剂A成品,将成品膏剂A装入软膏包装容器内即完成所有膏剂A加工工序,凡士林的用量保证中药原材料、西药原材料混合均匀即可。膏剂B中药原材料中,各原料份量如下:狼毒0.03份、蛇床子2份、厚朴0.6份、苦参1.5份、黄柏3份、珍珠0.4份、冰片2.2份.膏剂B西药原材料醋酸氯已定份量是0.2份。进行膏剂B的中药原材料、西药原材料混合加工制成膏剂B成品工序时,先将各中药原料用粉碎机粉碎至200目的粉末,把粉碎后药粉和醋酸氯已定在容器内调和均匀,调和过程中逐渐加入白凡士林,凡士林全部加入并调和均匀后即可得到膏剂B成品,将成品膏剂B装入软膏包装容器内即完成所有膏剂B加工工序,凡士林的用量保证中药原材料、西药原材料混合均匀即可。
图1中所示,实施例2中,膏剂A中药原材料中,各原料份量如下:土槿皮2.2份、苦参1.5份、蛇床子3.2份、白鲜皮2.2份、黄柏3.1份、五倍子1.5份、鞭蓉叶4份、皂角刺0.6份、独角莲3份、百部0.6份、土茯苓3.2份、七星剑0.6份、铁冬青0.7份。膏剂A西药原材料醋酸氯已定份量是0.5份。进行膏剂A的中药原材料、西药原材料混合加工制成膏剂A成品工序时,先将各中药原料用粉碎机粉碎至200目的粉末,把粉碎后药粉和醋酸氯已定在容器内调和均匀,调和过程中逐渐加入白凡士林,凡士林全部加入并调和均匀后即可得到膏剂A成品,将成品膏剂A装入软膏包装容器内即完成所有膏剂A加工工序,凡士林的用量保证中药原材料、西药原材料混合均匀即可。膏剂B中药原材料中,各原料份量如下:狼毒0.04份、蛇床子3份、厚朴0.7份、苦参2份、黄柏3.2份、珍珠0.6份、冰片2.3份.膏剂B西药原材料醋酸氯已定份量是0.25份。进行膏剂B的中药原材料、西药原材料混合加工制成膏剂B成品工序时,先将各中药原料用粉碎机粉碎至200目的粉末,把粉碎后药粉和醋酸氯已定在容器内调和均匀,调和过程中逐渐加入白凡士林,凡士林全部加入并调和均匀后即可得到膏剂B成品,将成品膏剂B装入软膏包装容器内即完成所有膏剂B加工工序,凡士林的用量保证中药原材料、西药原材料混合均匀即可。
图1中所示,本发明使用时,将牛皮癣表层用医疗工具刮干净,然后将膏剂A、膏剂B各适量涂抹在患处上并涂抹均匀,膏剂B用量为膏剂A的一半。然和结合曲安奈德注射液肌肉注射每天一次,外加内服黄柏胶囊每天六粒(注射及内服药物一般时间为一周)。膏剂A中,土荆皮中有效成分对牛皮癣常见的多种致病真菌,如许兰黄癣菌、絮状表皮癣菌、铁锈色小芽孢癣菌、石膏样小孢子菌和白色念珠菌等有良好的杀菌作用;苦参中所含的苦参碱(matrine)和金雀花碱(cytisine)等,有清热利湿,抗菌消炎的疗效,常用作治疗皮肤瘙痒,对牛皮癣有较好的治疗作用;蛇床子具有抗过敏作用,对治疗包括牛皮癣在内的过敏性皮肤疾病有较好疗效;白鲜皮具有清热解毒等功效;黄柏具有清热解毒,泻火燥湿等功效;五倍子具有收敛、抑菌、解毒等功效;鞭蓉叶具有凉血、解毒、消肿、止痛等功效;皂角刺具有搜风、拔毒、消肿、排脓、治痈肿等功效,用于疮毒,疠风,癣疮等的治疗;蛇床子具有燥湿、祛风、杀虫、温肾壮阳等功效;独角莲具有解毒散结等功效;百部具有散热解表等功效,用于皮肤疥癣、湿疹、牛皮癣等症的治疗;土茯苓具有除湿、解毒等功效;七星剑具有利湿解毒的功效;铁冬青具有清热解毒,消肿止痛的功效。膏剂B中:狼毒具有治疗疮瘘癣类等功效;厚朴具有具有行气化湿、温中止痛等的功效,对葡萄球菌、链球菌、赤痢杆菌、巴氏杆菌、霍乱弧菌有较强的抗菌作用;珍珠具有收敛生肌的功效,能加速患处肌肤的愈合;冰片具有消肿止痛等功效。本发明的曲安奈德注射液以及膏剂A、膏剂B、醋酸氯已定对牛皮癣致病菌金黄色葡萄球菌和白色念珠菌等均有良好的抑制作用,黄柏胶囊具有清热燥湿,泻火除蒸,解毒疗疮的功效,结合中药西药的共同作用,各中药和西药有效成分由内而外直接作用于患处,深入患处的血液循环,能促进患处的新陈代谢,达到好的排毒、去毒效果,显效快,从根源上治疗牛皮癣、且不易复发,即治标又治本,能起到好的治愈效果,且由于对发病根源进行了有效治疗,痊愈后不容易复发。本发明组方严谨、使用方便,治愈效果好,因此具有好的应用前景。
本发明对100例病例进行用药效果验证,分为用药组和普通组,100例测试者男女各50人,年龄阶段23至50岁左右,其中50例用药组采用本发明连续患处擦药30天,每天一次,外加注射一周注射曲安奈德注射液(一天一次)以及内服黄柏胶囊一周(一天六粒);另外50例采用普通治疗牛皮癣的外用药连续患处擦药30天,每天一次。经过30天连续用药,使用本发明的用药组牛皮癣治愈率为百分之九十五,使用普通治疗牛皮癣外用药的治愈率为百分之四十。后续经过一年的跟踪调查,使用本发明的用药组复发率仅为百分之三,使用普通治疗牛皮癣外用药的普通组复发率高达百分之七十。上述结果充分验证了本发明的疗效,以及本发明具有良好的防止复发效果。
以上显示和描述了本发明的基本原理和主要特征及本发明的优点,对于本领域技术人员而言,显然本发明限于上述示范性实施例的细节,而且在不背离本发明的精神或基本特征的情况下,能够以其他的具体形式实现本发明。因此,无论从哪一点来看,均应将实施例看作是示范性的,而且是非限制性的,本发明的范围由所附权利要求而不是上述说明限定,因此旨在将落在权利要求的等同要件的含义和范围内的所有变化囊括在本发明内。不应将权利要求中的任何附图标记视为限制所涉及的权利要求。
此外,应当理解,虽然本说明书按照实施方式加以描述,但并非每个实施方式仅包含一个独立的技术方案,说明书的这种叙述方式仅仅是为清楚起见,本领域技术人员应当将说明书作为一个整体,各实施例中的技术方案也可以经适当组合,形成本领域技术人员可以理解的其他实施方式。
Claims (7)
1.一种治疗牛皮癣的药物,包括曲安奈德注射液、黄柏胶囊,其特征在于还具有膏剂A、膏剂B,膏剂A包括中药原材料和西药原材料,膏剂A中药原材料包括土槿皮、苦参、蛇床子、白鲜皮、黄柏、五倍子、鞭蓉叶、皂角刺、独角莲、百部、土茯苓、七星剑、铁冬青,膏剂A西药原材料是醋酸氯已定,膏剂A的中药原材料、西药原材料混合加工制成膏剂A成品;膏剂B包括包括中药原材料和西药原材料,膏剂B中药原材料包括狼毒、蛇床子、厚朴、苦参、黄柏、珍珠、冰片,膏剂B西药原材料是醋酸氯已定,膏剂B的中药原材料、西药原材料混合加工制成膏剂B成品;加工而成的膏剂A、膏剂B即是治疗牛皮癣的药物成品。
2.根据权利要求1所述的一种治疗牛皮癣的药物,其特征在于膏剂A中药原材料中,各原料份量如下:土槿皮2-3份、苦参1-2份、蛇床子2-4份、白鲜皮2-2.5份、黄柏2-4份、五倍子1-2份、鞭蓉叶2-4份、皂角刺0.2-0.8份、独角莲2-4份、百部0.2-0.8份、土茯苓2-4份、七星剑0.2-0.8份、铁冬青0.3-0.8份。
3.根据权利要求1所述的一种治疗牛皮癣的药物,其特征在于膏剂A西药原材料醋酸氯已定份量是0.1-0.5份。
4.根据权利要求1所述的一种治疗牛皮癣的药物,其特征在于进行膏剂A的中药原材料、西药原材料混合加工制成膏剂A成品工序时,先将各中药原料用粉碎机粉碎至200目的粉末,把粉碎后药粉和醋酸氯已定在容器内调和均匀,调和过程中逐渐加入白凡士林,凡士林全部加入并调和均匀后即可得到膏剂A成品,将成品膏剂A装入软膏包装容器内即完成所有膏剂A加工工序,凡士林的用量保证中药原材料、西药原材料混合均匀即可。
5.根据权利要求1所述的一种治疗牛皮癣的药物,其特征在于膏剂B中药原材料中,各原料份量如下:狼毒0.03-0.06份、蛇床子2-4份、厚朴0.4-0.7份、苦参1-2份、黄柏2-4份、珍珠0.3-0.7份、冰片1.5-2.6份。
6.根据权利要求1所述的一种治疗牛皮癣的药物,其特征在于膏剂B西药原材料醋酸氯已定份量是0.1-0.3份。
7.根据权利要求1所述的一种治疗牛皮癣的药物,其特征在于进行膏剂B的中药原材料、西药原材料混合加工制成膏剂B成品工序时,先将各中药原料用粉碎机粉碎至200目的粉末,把粉碎后药粉和醋酸氯已定在容器内调和均匀,调和过程中逐渐加入白凡士林,凡士林全部加入并调和均匀后即可得到膏剂B成品,将成品膏剂B装入软膏包装容器内即完成所有膏剂B加工工序,凡士林的用量保证中药原材料、西药原材料混合均匀即可。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811238536.1A CN109200232A (zh) | 2018-10-23 | 2018-10-23 | 一种治疗牛皮癣的药物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811238536.1A CN109200232A (zh) | 2018-10-23 | 2018-10-23 | 一种治疗牛皮癣的药物 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN109200232A true CN109200232A (zh) | 2019-01-15 |
Family
ID=64979856
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811238536.1A Pending CN109200232A (zh) | 2018-10-23 | 2018-10-23 | 一种治疗牛皮癣的药物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109200232A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115463194A (zh) * | 2022-09-21 | 2022-12-13 | 中国海洋大学 | 一种新型治疗银屑病的中草药药膏及其制备方法 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101199787A (zh) * | 2007-12-06 | 2008-06-18 | 朱锋 | 一种治疗皮肤病的药物组合物 |
CN105233112A (zh) * | 2015-10-25 | 2016-01-13 | 四川双鑫生物科技有限公司 | 一种治疗神经性皮炎病的膏剂药物及其制备方法 |
CN107519438A (zh) * | 2017-08-31 | 2017-12-29 | 赣州佳忆生物科技有限公司 | 治疗皮肤瘙痒的组合物及其制备方法与应用 |
CN108404014A (zh) * | 2018-06-12 | 2018-08-17 | 杨光 | 治疗皮肤病中药组合物及制备方法 |
CN108578615A (zh) * | 2018-05-30 | 2018-09-28 | 武汉润禾生物医药有限公司 | 一种治疗瘙痒性皮肤病的抑菌软膏制备方法 |
-
2018
- 2018-10-23 CN CN201811238536.1A patent/CN109200232A/zh active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101199787A (zh) * | 2007-12-06 | 2008-06-18 | 朱锋 | 一种治疗皮肤病的药物组合物 |
CN105233112A (zh) * | 2015-10-25 | 2016-01-13 | 四川双鑫生物科技有限公司 | 一种治疗神经性皮炎病的膏剂药物及其制备方法 |
CN107519438A (zh) * | 2017-08-31 | 2017-12-29 | 赣州佳忆生物科技有限公司 | 治疗皮肤瘙痒的组合物及其制备方法与应用 |
CN108578615A (zh) * | 2018-05-30 | 2018-09-28 | 武汉润禾生物医药有限公司 | 一种治疗瘙痒性皮肤病的抑菌软膏制备方法 |
CN108404014A (zh) * | 2018-06-12 | 2018-08-17 | 杨光 | 治疗皮肤病中药组合物及制备方法 |
Non-Patent Citations (1)
Title |
---|
陈志伟: "《外阴肛周皮肤病中西医特色治疗》", 31 July 2013 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115463194A (zh) * | 2022-09-21 | 2022-12-13 | 中国海洋大学 | 一种新型治疗银屑病的中草药药膏及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3466447B1 (en) | Pharmaceutical composition for treating multiple forms of skin wounds and manufacturing method thereof | |
CN109248240A (zh) | 用于跌打损伤的药物组合物及其制备方法 | |
CN102406766B (zh) | 一种治疗骨折的中药组合物及其应用 | |
CN109200232A (zh) | 一种治疗牛皮癣的药物 | |
CN105434795A (zh) | 一种含有艾叶的外敷治疗骨质增生的中药制剂 | |
CN104208242A (zh) | 一种治疗前列腺炎的外用贴剂及其制备方法 | |
CN104825941A (zh) | 一种治疗脚气的中草药组合物及其制备方法 | |
CN107648444A (zh) | 一种用于外阴脂溢性皮炎的缓释性透皮给药贴 | |
CN107669956A (zh) | 治疗犬、猫耳病的中药制剂及其制备方法 | |
CN105327244A (zh) | 一种含有艾叶的治疗褥疮的中药组合物及其制备方法 | |
CN111773341A (zh) | 一种治疗仔猪疥癣病的复方中草药外用制剂 | |
CN104873723B (zh) | 一种含肉桂油的烧烫伤药 | |
CN106334176B (zh) | 一种可以消肿止痛止痒的冻疮膏及其制备方法 | |
CN105168503B (zh) | 一种用于防治放射性皮炎的外用中药组合物及其制备方法 | |
CN108567963B (zh) | 一种治疗骨性关节炎的透骨草组合物 | |
CN108785398A (zh) | 一种含有牡丹籽油的镇痛复合油及其制备方法与应用 | |
CN107714781B (zh) | 治疗烧烫伤的药物组合物及其制备方法和应用 | |
CN106729631A (zh) | 治疗顽固性皮肤溃疡的外用喷剂 | |
CN104474469A (zh) | 一种制备用于电灼伤膏状制剂的方法 | |
CN106581660A (zh) | 一种治疗微生物感染的组合物 | |
CN117045732A (zh) | 一种用于脂肪瘤的中药组合物及其制备方法和应用 | |
CN120392893A (zh) | 一种促进腹部手术患者术后肠道功能恢复的中药组合物及其制备方法和用途 | |
CN105030888A (zh) | 治疗鳞屑角化型鹅掌风及脚癣的中药膏及其使用方法 | |
CN101574448B (zh) | 适用于治疗骨质增生的外用中药组合物及其制备方法 | |
CN105497535A (zh) | 一种治疗电灼伤制剂的制备工艺 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190115 |
|
RJ01 | Rejection of invention patent application after publication |